Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

NCT06238024 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Interleukin-6
Ischemic Stroke
Endovascular Treatment

Interventions

DRUG: Tocilizumab
DRUG: NaCl 0.9% 100ml

Sponsor

Suzhou Municipal Hospital of Anhui Province

Collaborators

[object Object]